Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Dec 15;194(12):1448-1451.
doi: 10.1164/rccm.201607-1431ED.

New Evidence for the Complexity of the Population Structure of Mycobacterium tuberculosis Increases the Diagnostic and Biologic Challenges

Affiliations
Comment

New Evidence for the Complexity of the Population Structure of Mycobacterium tuberculosis Increases the Diagnostic and Biologic Challenges

Véronique Dartois et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Intersubject variability in culture methods detecting Mycobacterium tuberculosis (Mtb) in sputum and implications for case detection. Each of the 110 subjects for whom results were analyzed is represented according to Mtb culture method positivity (9). Also represented are 22 subjects who were excluded from analysis but were described as having a positive mycobacterial growth indicator tube (MGIT), cfu, or GeneXpert test. The individual’s color classifies the predominant population identified, and they are grouped according to detection method positivity. Not all subjects’ sputum was tested by every method, and available information did not allow subgrouping by sputum smear positivity and GeneXpert positivity. In this patient population preselected by GeneXpert or smear positivity, no single culture method detected all cases. CF = culture filtrate; DCTB = differentially culturable tubercle bacilli; MPN = most probable number; Rpf = resuscitation-promoting factors.

Comment on

References

    1. Lenaerts A, Barry CE, III, Dartois V. Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol Rev. 2015;264:288–307. - PMC - PubMed
    1. Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis. 2009;9:162–172. - PubMed
    1. Shenai S, Amisano D, Ronacher K, Kriel M, Banada PP, Song T, Lee M, Joh JS, Winter J, Thayer R, et al. Exploring alternative biomaterials for diagnosis of pulmonary tuberculosis in HIV-negative patients by use of the GeneXpert MTB/RIF assay. J Clin Microbiol. 2013;51:4161–4166. - PMC - PubMed
    1. Diacon AH, Donald PR. The early bactericidal activity of antituberculosis drugs. Expert Rev Anti Infect Ther. 2014;12:223–237. - PubMed
    1. Mukamolova GV, Turapov O, Malkin J, Woltmann G, Barer MR. Resuscitation-promoting factors reveal an occult population of tubercle bacilli in sputum. Am J Respir Crit Care Med. 2010;181:174–180. - PMC - PubMed

Substances